Unlocking Sustainable Weight Loss with GLP1 Medications and Peptides at Illume Med Spa & Wellness Apr 18, 2025 2 min read In the evolving landscape of weight management, GLP-1 receptor agonists and peptides have emerged as transformative tools
Hursel, R., Viechtbauer, W., & Westerterp-Plantenga, M
Economic stratification across neighborhoods creates vastly different access to health resources, premium foods, and wellness facilities throughout the metro
Bisgaard LS, Bosteen MH, Fink LN, Srensen CM, Rosendahl A, Mogensen CK, Rasmussen SE, Rolin B, Nielsen LB, Pedersen TX
There is downtime with these
The five most at-risk states: West Virginia Awareness Gap Index: 78.8 (24% GLP-1 usage and 77 searches per 100,000 residents) Kentucky Awareness Gap Index: 76.7 (22% GLP-1 usage and 74 searches per 100,000 residents) Oklahoma Awareness Gap Index: 76.4 (20% GLP-1 usage and 69 searches per 100,000 residents) Alaska Awareness Gap Index: 73.3 (17% GLP-1 usage and 64 searches per 100,000 residents) Alabama Awareness Gap Index: 69.6 (19% GLP-1 usage and 72 searches per 100,000 residents) At the other end of the table, the five safest states benefit primarily from lower prescription rates rather than superior awareness fewer people on the drugs means fewer people exposed to the risk